Matthias T Heemskerk

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Pseudomonas Aeruginosa

Positive Breast Cancer

Top Venues

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Gül Kilinç, Ralf Boland, Matthias T Heemskerk, Herman P Spaink, Marielle C Haks, Michiel Van Der Vaart, Tom H M Ottenhoff, Annemarie H Meijer, Anno Saris
Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Microbiology spectrum 12 (8) (2024)
Gül Kilinç, Ralf Boland, Matthias T Heemskerk, Herman P Spaink, Marielle C Haks, Michiel Van Der Vaart, Tom H M Ottenhoff, Annemarie H Meijer, Anno Saris
Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Microbiology spectrum (2024)
Gül Kilinç, Ralf Boland, Matthias T Heemskerk, Herman P Spaink, Marielle C Haks, Michiel Van Der Vaart, Tom H M Ottenhoff, Annemarie H Meijer, Anno Saris
Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Microbiology spectrum (2024)
Ralf Boland, Matthias T Heemskerk, Gabriel Forn-Cuní, Cornelis J Korbee, Kimberley V Walburg, Jeroen J Esselink, Carina Carvalho Dos Santos, Amy M de Waal, Daniel C M van der Hoeven, Elisa van der Sar, Alex S de Ries, Jiajun Xie, Herman P Spaink, Michiel Van Der Vaart, Marielle C Haks, Annemarie H Meijer, Tom H M Ottenhoff
Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis. mBio (2022)